This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meggouh, F. Articles by Saez, S. Search for Related Content PubMed PubMed Citation Articles by Meggouh, F. Articles by Saez, S.

Sex Steroid and 1,25-Dihydroxyvitamin D₃ Receptors in Human Colorectal Adenocarcinoma and Normal Mucosa¹

Laboratoire de Biologie Médicale, Centre Léon Bérard, Rue Laënnec, 69373 Lyon [F. M., S. S.], and Service de Chirurgie Générale and Digestive, Hotel-Dieu, BP 69, 63003, Clermont-Ferrand [P. L.], France

In order to determine the potential role of sex steroid and 1,25-dihydroxyvitamin D₃ in the spreading of colorectal cancer, previously hypothesized from epidemiological and experimental data, specific androgen (AR, n = 94), estrogen (ER, n = 60), progesterone (PGR, n = 50), and 1,25-dihydroxyvitamin D₃ receptors (VDR, (n = 111) were investigated in human colorectal adenocarcinoma (AC) and compared with the normal adjacent mucosa (NM).

Scatchard analysis and competition studies of binding data did not reveal any difference between the biochemical behavior (affinity, specificity, and sedimentation coefficient) of the normal and tumoral tissue receptors. For ARs and ERs, high incidences were found (92 of 94 and 90 of 94 in NM versus 46 of 60 and 40 of 60 in AC, respectively) in both classes of tissues, while they were low for progesterone (7 of 50 and 5 of 50 in NM versus AC). While for sex steroid receptors the incidences did not vary with sex and age of the patients or the location and histopathological grade of the tumor, the VDR incidence was lower in AC (35 of 111) than in NM (99 of 111) and decreased significantly from the right colon to the rectum in adenocarcinoma. Binding capacities were similar in NM and AC for ERs and VDRs, whereas AR levels in NM were significantly higher than in AC.

The expression of VDRs in some colorectal tumors suggests a possible clinical significance. No known function for sex steroid receptors is related to their presence in human colorectal tissues and their pattern in carcinoma does not support any hypothesis previously raised in the case of chemically induced colonic tumors in rodents.

¹ This work was supported by grants from Fédération Nationale des Centres de Lutte contre le Cancer and Ligue Nationale Française contre le Cancer.

² To whom requests for reprints should be addressed, at Laboratoire de Biologie Médicale, Centre Léon Bérard, Rue Laënnec, 69373 Lyon, France.

Received 6/20/90. Accepted 12/ 4/90.

This article has been cited by other articles:

				B. NURNBERG, S. GRABER, B. GARTNER, J. GEISEL, C. PFOHLER, D. SCHADENDORF, W. TILGEN, and J. REICHRATH Reduced Serum 25-Hydroxyvitamin D Levels in Stage IV Melanoma Patients Anticancer Res, September 1, 2009; 29(9): 3669 - 3674. [Abstract] [Full Text] [PDF]

				W. BROZEK, S. KRIWANEK, E. BONNER, M. PETERLIK, and H. S. CROSS Mutual Associations between Malignancy, Age, Gender, and Subsite Incidence of Colorectal Cancer Anticancer Res, September 1, 2009; 29(9): 3721 - 3726. [Abstract] [Full Text] [PDF]

				K. Ng, J. A. Meyerhardt, K. Wu, D. Feskanich, B. W. Hollis, E. L. Giovannucci, and C. S. Fuchs Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer J. Clin. Oncol., June 20, 2008; 26(18): 2984 - 2991. [Abstract] [Full Text] [PDF]

				H. A Bischoff-Ferrari, E. Giovannucci, W. C Willett, T. Dietrich, and B. Dawson-Hughes Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am. J. Clinical Nutrition, July 1, 2006; 84(1): 18 - 28. [Abstract] [Full Text] [PDF]

				D. J. Mulholland, S. Dedhar, G. A. Coetzee, and C. C. Nelson Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know? Endocr. Rev., December 1, 2005; 26(7): 898 - 915. [Abstract] [Full Text] [PDF]

				L. A. Gilad, T. Bresler, J. Gnainsky, P. Smirnoff, and B. Schwartz Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells J. Endocrinol., June 1, 2005; 185(3): 577 - 592. [Abstract] [Full Text] [PDF]

				M. Campbell-Thompson, I. J. Lynch, and B. Bhardwaj Expression of Estrogen Receptor (ER) Subtypes and ER{beta} Isoforms in Colon Cancer Cancer Res., January 1, 2001; 61(2): 632 - 640. [Abstract] [Full Text]

				G. D. Díaz, C. Paraskeva, M. G. Thomas, L. Binderup, and A. Hague Apoptosis Is Induced by the Active Metabolite of Vitamin D3 and Its Analogue EB1089 in Colorectal Adenoma and Carcinoma Cells: Possible Implications for Prevention and Therapy Cancer Res., April 1, 2000; 60(8): 2304 - 2312. [Abstract] [Full Text]

				Y. Liel, S. Shany, P. Smirnoff, and B. Schwartz Estrogen Increases 1,25-Dihydroxyvitamin D Receptors Expression and Bioresponse in the Rat Duodenal Mucosa Endocrinology, January 1, 1999; 140(1): 280 - 285. [Abstract] [Full Text]